DAWN
Day One Biopharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$21.53
+0.00%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
+79.0%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Feb 18, 2026 | Bender Jeremy · director, officer: CHIEF EXECUTIVE OFFICER | Sale | 15,459 | $12 |
| Feb 18, 2026 | Dubow Adam · officer: Gen Counsel & Secretary | M-Exempt | 2,963 | $0.00 |
| Feb 18, 2026 | Bender Jeremy · director, officer: CHIEF EXECUTIVE OFFICER | M-Exempt | 4,750 | $0.00 |
| Feb 18, 2026 | York Charles N II · officer: COO and CFO | Sale | 6,065 | $12 |
| Feb 18, 2026 | Dubow Adam · officer: Gen Counsel & Secretary | M-Exempt | 3,688 | $0.00 |
| Feb 18, 2026 | Bender Jeremy · director, officer: CHIEF EXECUTIVE OFFICER | M-Exempt | 11,688 | $0.00 |
| Feb 18, 2026 | York Charles N II · officer: COO and CFO | M-Exempt | 6,625 | $0.00 |
| Feb 18, 2026 | Dubow Adam · officer: Gen Counsel & Secretary | M-Exempt | 1,750 | $0.00 |
| Feb 18, 2026 | Dubow Adam · officer: Gen Counsel & Secretary | Sale | 6,395 | $12 |
| Feb 18, 2026 | Merendino Lauren · officer: Chief Commercial Officer | Sale | 5,814 | $12 |
| Feb 18, 2026 | Bender Jeremy · director, officer: CHIEF EXECUTIVE OFFICER | M-Exempt | 14,812 | $0.00 |
| Feb 18, 2026 | Dubow Adam · officer: Gen Counsel & Secretary | M-Exempt | 4,375 | $0.00 |
| Feb 18, 2026 | Bender Jeremy · director, officer: CHIEF EXECUTIVE OFFICER | M-Exempt | 11,687 | $0.00 |
| Feb 18, 2026 | Dubow Adam · officer: Gen Counsel & Secretary | M-Exempt | 3,687 | $0.00 |
| Feb 18, 2026 | VASCONCELLES MICHAEL · officer: Head of Research and Dev. | M-Exempt | 7,125 | $0.00 |
| Feb 18, 2026 | York Charles N II · officer: COO and CFO | M-Exempt | 7,875 | $0.00 |
| Feb 18, 2026 | VASCONCELLES MICHAEL · officer: Head of Research and Dev. | Sale | 2,728 | $12 |
| Feb 18, 2026 | Merendino Lauren · officer: Chief Commercial Officer | M-Exempt | 3,688 | $0.00 |
| Feb 18, 2026 | Merendino Lauren · officer: Chief Commercial Officer | M-Exempt | 3,162 | $0.00 |
| Feb 18, 2026 | Merendino Lauren · officer: Chief Commercial Officer | M-Exempt | 3,687 | $0.00 |
| Feb 18, 2026 | Merendino Lauren · officer: Chief Commercial Officer | M-Exempt | 4,625 | $0.00 |
| Feb 18, 2026 | York Charles N II · officer: COO and CFO | M-Exempt | 2,250 | $0.00 |
| Jan 30, 2026 | Bender Jeremy · director, officer: CHIEF EXECUTIVE OFFICER | A-Award | 237,000 | $0.00 |
| Jan 30, 2026 | VASCONCELLES MICHAEL · officer: Head of Research and Dev. | A-Award | 114,000 | $0.00 |
| Jan 30, 2026 | Bender Jeremy · director, officer: CHIEF EXECUTIVE OFFICER | A-Award | 355,000 | $11 |
| Jan 30, 2026 | Dubow Adam · officer: Gen Counsel & Secretary | A-Award | 105,000 | $11 |
| Jan 30, 2026 | VASCONCELLES MICHAEL · officer: Head of Research and Dev. | A-Award | 171,000 | $11 |
| Jan 30, 2026 | York Charles N II · officer: COO and CFO | A-Award | 126,000 | $0.00 |
| Jan 30, 2026 | Merendino Lauren · officer: Chief Commercial Officer | A-Award | 74,000 | $0.00 |
| Jan 30, 2026 | Merendino Lauren · officer: Chief Commercial Officer | A-Award | 110,000 | $11 |
Institutional positioning
13F filings over the trailing two quarters
New 86Increased 65Reduced 48Sold out 209
| Filer | Action | Shares | Filed |
|---|---|---|---|
| BLACKROCK, INC. | Reduced | 7,044,487 | May 13, 2026 |
| GLAZER CAPITAL, LLC | New Position | 4,683,687 | May 14, 2026 |
| FIL LTD | New Position | 4,131,907 | May 15, 2026 |
| Kryger Capital LLC | New Position | 3,896,485 | May 14, 2026 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | Unchanged | 3,723,131 | May 15, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 3,357,684 | May 15, 2026 |
| JPMORGAN CHASE & CO | Increased | 3,134,753 | May 13, 2026 |
| STATE STREET CORP | Reduced | 2,869,876 | May 15, 2026 |
| BALYASNY ASSET MANAGEMENT L.P. | Increased | 2,625,235 | May 15, 2026 |
| AQR ARBITRAGE LLC | New Position | 2,462,154 | May 15, 2026 |
| UBS GROUP AG | Increased | 2,305,123 | May 5, 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | New Position | 2,095,813 | May 8, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 1,954,735 | May 15, 2026 |
| QUBE RESEARCH & TECHNOLOGIES LTD | Increased | 1,954,552 | May 15, 2026 |
| MILLENNIUM MANAGEMENT LLC | Increased | 1,927,557 | May 15, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Feb 18, 2026